Dianthus Therapeutics News

LifeSci Capital Maintains Dianthus Therapeutics(DNTH.US) With Buy Rating, Maintains Target Price $45

Futu NewsDec 13 20:31

Oppenheimer Initiates Dianthus Therapeutics(DNTH.US) With Buy Rating, Announces Target Price $52

Futu NewsNov 11 21:31

Dianthus Therapeutics Price Target Raised to $52.00/Share From $48.00 by Oppenheimer

Dow JonesNov 11 21:30

Dianthus Therapeutics Is Maintained at Outperform by Oppenheimer

Dow JonesNov 11 21:30

Dianthus Therapeutics Analyst Ratings

BenzingaNov 9 01:46

Raymond James Maintains Outperform on Dianthus Therapeutics, Raises Price Target to $56

BenzingaNov 9 01:46

LifeSci Capital Maintains Dianthus Therapeutics(DNTH.US) With Buy Rating, Maintains Target Price $45

Futu NewsNov 8 10:32

Baird Maintains Dianthus Therapeutics(DNTH.US) With Buy Rating, Maintains Target Price $58

Futu NewsOct 8 06:31

Guggenheim Initiates Dianthus Therapeutics(DNTH.US) With Buy Rating

Futu NewsOct 5 06:32

Dianthus Therapeutics Analyst Ratings

BenzingaOct 3 20:07

Oppenheimer Initiates Dianthus Therapeutics at Outperform With $48 Price Target

MT NewswiresOct 3 18:38

H.C. Wainwright Maintains Dianthus Therapeutics(DNTH.US) With Buy Rating, Maintains Target Price $40

Futu NewsSep 26 18:33

Analysts Offer Insights on Healthcare Companies: Xenon (XENE), Nuvalent (NUVL) and Dianthus Therapeutics (DNTH)

TipRanksAug 13 21:45

Dianthus Therapeutics Analyst Ratings

BenzingaAug 13 02:50

HC Wainwright & Co. Reiterates Buy on Dianthus Therapeutics, Maintains $40 Price Target

BenzingaAug 13 02:50

Promising Clinical Developments Bolster Buy Rating for Dianthus Therapeutics

TipRanksAug 12 18:25

Wedbush Remains a Buy on Dianthus Therapeutics (DNTH)

TipRanksAug 9 21:29

Dianthus Therapeutics Receives 'Buy' Rating on Strong Financials and Promising Drug Pipeline

TipRanksAug 9 20:57

Baird Starts Dianthus Therapeutics With Outperform Rating, $58 Price Target

MT NewswiresJul 26 19:28

Dianthus Therapeutics Analyst Ratings

BenzingaJul 26 17:15